Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

HOME
Pharma Business
About us
- Media Kit
- Privacy Policy
Contact

Search for:

Tag: elyad

Celyad advances first NKG2D CAR T-Cell Phase I study

December 1, 2015 Off

Celyad advances first NKG2D CAR T-Cell Phase I study

By Dino Mustafić

Celyad advances first NKG2D CAR T-Cell Phase I study

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)

December 5, 2025 Off

Cosentyx meets the primary endpoints

June 15, 2015 Off

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine